A novel plant lectin, NTL-125, interferes with SARS-CoV-2 interaction with hACE2.
A new plant lectin called NTL-125 from Narcissus tazetta bulb has been identified as an effective inhibitor of SARS-CoV-2 replication. The lectin has been shown in in silico docking studies to prevent the virus from attaching to the cellular entryway, hACE2 receptor, by binding strongly to the viral Spike RBD protein. Mutant variants of the protein also showed stronger affinity to NTL-125 than hACE2. This natural antiviral compound may serve as an important therapeutic for COVID-19 management despite the virus's tendency to mutate.
- Sarkar A et al (2022).
- Virus Res.
- PubMed:
- 35398454